[The use of verapamil in tests for determining the drug resistance of leukemic blasts].

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Back to search

Article

[The use of verapamil in tests for determining the drug resistance of leukemic blasts].

Gematologiia i transfuziologiia - 1 May 1993

Mukhammed A, Turkina A G, Al'pidovskiĭ V K, Sidorova T A, Golenko O D, Gerasimova G K

Abstract excerpt

To determine prognostically unfavourable groups of acute leukemia patients, the authors studied the in vitro accumulation of 3H-vincristine (Vcr) and adriamycin (ADR) as well as inclusion of 3H-cytosar (Ara-C) into marrow blast DNA from patients showing different effects of treatment. It was foun...

Topics

Adolescent
Adult
Aged
Drug Resistance
Drug Screening Assays, Antitumor
Humans
Leukemia, Myeloid, Acute
Middle Aged
Phenotype
Precursor Cell Lymphoblastic Leukemia-Lymphoma
Tritium
Tumor Cells, Cultured
Verapamil

Source

Open in PubMed

Identifiers

PMID: 8034162

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 30 Aug 2026. Prepared record publication-8034162-2026-08-30.1. Manifest publication-graph-cohort-2026-08-30.1.

Source receipt: PubMed via Helena Literature Corpus, retrieved 30 Aug 2026.

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

discussions

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics